Legal Representation
Attorney
Michael R. Graif
USPTO Deadlines
Next Deadline
82 days remaining
Statement of Use Due - Extension 5 Granted
Due Date
November 01, 2025
Application History
47 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 1, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Aug 1, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Aug 1, 2025 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Aug 1, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Mar 17, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Mar 17, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Mar 17, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Mar 13, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 13, 2025 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Mar 3, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 3, 2025 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Sep 4, 2024 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Sep 4, 2024 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Sep 4, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 4, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 6, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 4, 2024 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Mar 4, 2024 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Mar 4, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 4, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 13, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 11, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Sep 11, 2023 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Sep 11, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 9, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 8, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Aug 7, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jun 26, 2023 | NREV | E | NOTICE OF REVIVAL - E-MAILED | Loading... |
| Jun 25, 2023 | TPEX | I | SOU EXTENSION RECEIVED WITH TEAS PETITION | Loading... |
| Jun 25, 2023 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
| Jun 25, 2023 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
| Jun 15, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jun 15, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jun 15, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jun 15, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jun 15, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Jun 5, 2023 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Jun 5, 2023 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| May 1, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Nov 1, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 6, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 6, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 17, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 1, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 1, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 16, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 12, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the prevention of cancer and immunological diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for the treatment and prevention of cancer and immunological diseases and disordersocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations, namely, antivirals
Additional Information
Pseudo Mark
T BOLT
Classification
International Classes
005